Patent details

EP2066354 Title: NOROVIRUS VACCINE FORMULATIONS

Basic Information

Publication number:
EP2066354
PCT Application Number:
PCT/US/2007/079929
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP078536885
PCT Publication Number:
WO/2008/042789
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NOROVIRUS VACCINE FORMULATIONS
French Title of Invention:
FORMULATIONS DE VACCIN CONTRE UN NOROVIRUS
German Title of Invention:
NOROVIRUS-IMPFSTOFFFORMULIERUNGEN
SPC Number:

Dates

Filing date:
28/09/2007
Grant date:
17/04/2013
EP Publication Date:
17/04/2013
PCT Publication Date:
10/04/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/06/2009
EP B1 Publication Date:
17/04/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
28/09/2013
Expiration date:
28/09/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/09/2007
 
 

Name:
Ligocyte Pharmaceuticals Inc.
Address:
2155 Analysis Drive, Bozeman, MT 59718, United States (US)

Inventor

1

Name:
RICHARDSON Charles
Address:
United States (US)

2

Name:
TINO William, T.
Address:
United States (US)

3

Name:
VEDVICK Thomas, S.
Address:
United States (US)

4

Name:
FOUBERT Thomas, R.
Address:
United States (US)

Priority

1

Priority Number:
847912 P
Priority Date:
29/09/2006
Priority Country:
United States (US)

2

Priority Number:
973392 P
Priority Date:
18/09/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 39/125;
Filing date Document type Number of pages